本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Altamira Therapeutics Ltd.

0.3000
+0.0000
成交量:- -
成交額:- -
市值:113.36萬
市盈率:-0.16
高:0.3000
開:0.3000
低:0.3000
收:0.3000
資料載入中...
2024/11/14

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/17

SEC問詢函

Form CORRESP - Correspondence
2024/09/17

SEC問詢函

Form CORRESP - Correspondence
2024/09/16

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/09/16

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/08/22

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/07/01

[修訂]年度報告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2024/04/22

[修訂]年度報告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2024/04/17

SEC問詢函

Form CORRESP - Correspondence
2024/04/10

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/04/10

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/04/10

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/13

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/17

SEC問詢函

Form CORRESP - Correspondence
2023/07/05

SEC問詢函

Form CORRESP - Correspondence
2023/07/05

SEC問詢函

Form CORRESP - Correspondence
2023/07/05

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/06/16

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2023/06/09

SEC問詢函

Form CORRESP - Correspondence
2023/06/09

SEC問詢函

Form CORRESP - Correspondence